• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAmpio Pharmaceuticals
    Picture of Ampio Pharmaceuticals logo

    AMPE — Ampio Pharmaceuticals News Story

    $0.180.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
    • Enterprise Value
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AMPE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AMPE Dividends
    All News

    AMEX RESUMED

    Picture of Ampio Pharmaceuticals logoAmpio Pharmaceuticals
    14/06/2019 15:18
    AMEX RESUMED  AMPE.A
    

    Recent news on Ampio Pharmaceuticals

    See all news
    • Brief: Ampio Announces Voluntary Delisting And SEC Deregistration

      25/03/2024 21:02
    • Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies

      14/02/2024 22:56
    • Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201

      05/10/2023 21:31
    • Brief: Ampio Pharmaceuticals Announces Reverse Stock Split

      31/08/2023 11:31
    • Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank

      13/03/2023 21:25

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.